Medical News

RSS

Antiretroviral therapy reduces mortality rates in patients co-infected with HIV and TB

Initiating antiretroviral therapy (ART) during tuberculosis therapy significantly reduced mortality rates by 56 percent in a randomized clinical trial of 642 patients co-infected with HIV and tuberculosis. The study, which provides further impetus for the integration of TB and HIV services, lays to rest the controversy on whether co-infected patients should initiate ART during or after TB treatment.

26 Feb 2010

Exergames improve mood and mental health-related quality of life in seniors with SSD

Research at the Sam and Rose Stein Institute for Research on Aging at the University of California, San Diego School of Medicine suggests a novel route to improving the symptoms of subsyndromal depression (SSD) in seniors through the regular use of "exergames" - entertaining video games that combine game play with exercise. In a pilot study, the researchers found that use of exergames significantly improved mood and mental health-related quality of life in older adults with SSD.

26 Feb 2010

SCI Alliance Acquisition extends expiry time of offer for Keystone North America

Service Corporation International, the largest provider of deathcare products and services in North America, announced today that its wholly-owned subsidiary, SCI Alliance Acquisition Corporation, has extended the expiry time of its offer dated November 16, 2009, as amended, to purchase all of the issued and outstanding common shares in the capital of Keystone North America Inc..

26 Feb 2010

NCCN Guidelines: Chemosensitivity/resistance assays to be part of Principles of Chemotherapy section

Precision Therapeutics announced today that The National Comprehensive Cancer Network® recently updated the NCCN Clinical Practice Guidelines for Oncology for Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer to include the use of chemosensitivity/resistance assays as part of the Principles of Chemotherapy section.

26 Feb 2010

Report highlighting the benefits of non-formal learning for older men in Belfast to be launched

A report from the Changing Ageing Partnership which highlights the benefits of non-formal learning for older men in Belfast will be launched at a conference in Australia today (Friday 26 February).

26 Feb 2010

Pall Corporation announces next generation, 96-well AcroPrep Advance filter plates

Pall Corporation, a global leader in filtration, separation and purification, has introduced its next generation 96-well filter plate that delivers consistency and reproducibility in applications, such as neonatal screening and multiplexing. The Pall AcroPrep Advance filter plate employs new design features that provide uniform filtration rates, lowers hold-up volumes and ensures consistent sample/bead recovery from the wells.

From Pall Corporation 26 Feb 2010

Avoiding dairy products due to lactose intolerance may pose diet and health risks, say experts

People may avoid milk and other dairy products due to concerns about lactose intolerance, but eliminating these nutrient-rich foods may not only be unnecessary to manage the condition - it could impact diet and health, concludes a panel of experts assembled by the National Institutes of Health (NIH).

26 Feb 2010

Guidant conceals defibrillator safety problems from FDA, is charged with criminal violations

Medical device manufacturer Guidant LLC, a wholly-owned subsidiary of Boston Scientific Corporation, was charged today with criminal violations of the Federal Food, Drug, and Cosmetic Act related to safety problems with some of its implantable defibrillators. Guidant LLC formerly did business as Guidant Corporation. The Justice Department filed the criminal information today in connection with an agreement with Guidant to resolve the charges. A formal guilty plea agreement is expected to be filed with the court at a later date.

26 Feb 2010

Maternal sensitivity may influence language development among children in early stages of autism

A new study by researchers from the University of Miami shows that maternal sensitivity may influence language development among children who go on to develop autism. Although parenting styles are not considered as a cause for autism, this report examines how early parenting can promote resiliency in this population.

26 Feb 2010

Lack of chemistry between Obama and GOP leaders could strain summit; Gingrich urges series of smaller bills

The New York Times reports on a lack of chemistry between President Barack Obama and leading Republicans such as Rep. John A. Boehner, the House Republican leader, and Senate Minority Leader Mitch McConnell.

26 Feb 2010

SynCare receives NCQA Accreditation for high-risk pregnancy program

SynCare, LLC has received National Committee for Quality Assurance Patient and Practitioner Oriented Full Accreditation for its high-risk pregnancy program, the SynCare Promise Program™ for Prenatal Care.

26 Feb 2010

BPA exposure during pregnancy may cause permanent reproduction problems for female offspring

Here's more evidence that "safe" plastics are not as safe as once presumed: New research published online in The FASEB Journal suggests that exposure to Bisphenol A (BPA) during pregnancy leads to epigenetic changes that may cause permanent reproduction problems for female offspring. BPA, a common component of plastics used to contain food, is a type of estrogen that is ubiquitous in the environment.

26 Feb 2010

Manhattan Scientifics completes agreement to acquire all commercial rights to Senior Scientific

Manhattan Scientifics Inc., a nanomedicine technology transfer and commercialization pioneer, today announced completion of its agreement to acquire all commercial rights to the body of work of nuclear physicist Edward R. Flynn, PhD and his company, Senior Scientific LLC.

26 Feb 2010

Accelerated radiation therapy helps reduce amount of chemotherapy in advanced head and neck cancer patients

Using an accelerated, shorter course of radiation therapy for patients with advanced head and neck cancer allows doctors to reduce the amount of chemotherapy, thus reducing toxicity, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.

26 Feb 2010

Misperceptions about risk, symptoms and lethality of lung cancer increase mortality rates for lung cancer

A new analysis published this week in the journal Cancer indicates that misperceptions about risk, symptoms and the lethality of lung cancer may play a role in the disproportionately higher incidence and mortality rates for lung cancer among African Americans.

26 Feb 2010

Study confirms efficacy and tolerability of lacosamide for uncontrolled POS

A recent multi-center study has confirmed earlier study results that 400 mg/day of lacosamide provides a good balance of efficacy and tolerability for patients with uncontrolled partial-onset seizures (POS), and doses of 600mg/day may provide additional benefit for some patients.

26 Feb 2010

RMEI, PIM jointly sponsor complimentary continuing education virtual lecture on HAE

Hereditary angioedema (HAE) can be difficult to accurately diagnose and equally difficult to effectively treat. To overcome the many obstacles to managing the care of patients with HAE, healthcare professionals must be aware of the most up-to-date clinical data regarding HAE diagnosis and treatment.

26 Feb 2010

Medicare fraud: Brookhaven Memorial Hospital Medical Center agrees to pay $2.92M for resolving allegations

Brookhaven Memorial Hospital Medical Center, a Long Island, N.Y.-based hospital, has agreed to pay $2.92 million, plus interest, to settle allegations that the hospital defrauded Medicare, the Justice Department announced today.

26 Feb 2010

House passes bill to repeal antitrust exemption for health insurers

he House passed legislation Wednesday (406-19) to strip health insurers of their federal antitrust exemption.

26 Feb 2010

Resverlogix commences enrollment in RVX-208 Phase 2 clinical trial for atherosclerosis in ACS patients

Resverlogix Corp. announced today that it has officially activated the first site for the ASSURE 1 trial and commenced enrollment of patients for dosing of RVX-208. ASSURE 1 is the second Resverlogix Phase 2 clinical trial, led by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with acute coronary syndrome (ACS). This preparatory acute coronary syndrome study will ensure that 50 percent of the enrolled patients receive the IVUS (intravascular ultrasound) assessment.

26 Feb 2010

Medical News

Antiretroviral therapy reduces mortality rates in patients co-infected with HIV and TB

Exergames improve mood and mental health-related quality of life in seniors with SSD

SCI Alliance Acquisition extends expiry time of offer for Keystone North America

NCCN Guidelines: Chemosensitivity/resistance assays to be part of Principles of Chemotherapy section

Report highlighting the benefits of non-formal learning for older men in Belfast to be launched

Pall Corporation announces next generation, 96-well AcroPrep Advance filter plates

Avoiding dairy products due to lactose intolerance may pose diet and health risks, say experts

Guidant conceals defibrillator safety problems from FDA, is charged with criminal violations

Maternal sensitivity may influence language development among children in early stages of autism

Lack of chemistry between Obama and GOP leaders could strain summit; Gingrich urges series of smaller bills

SynCare receives NCQA Accreditation for high-risk pregnancy program

BPA exposure during pregnancy may cause permanent reproduction problems for female offspring

Manhattan Scientifics completes agreement to acquire all commercial rights to Senior Scientific

Accelerated radiation therapy helps reduce amount of chemotherapy in advanced head and neck cancer patients

Misperceptions about risk, symptoms and lethality of lung cancer increase mortality rates for lung cancer

Study confirms efficacy and tolerability of lacosamide for uncontrolled POS

RMEI, PIM jointly sponsor complimentary continuing education virtual lecture on HAE

Medicare fraud: Brookhaven Memorial Hospital Medical Center agrees to pay $2.92M for resolving allegations

House passes bill to repeal antitrust exemption for health insurers

Resverlogix commences enrollment in RVX-208 Phase 2 clinical trial for atherosclerosis in ACS patients

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News